DalalStreet Insider

  Tata Motors Technical Analysis: Multi-Timeframe Breakout Signals Rally to ₹800 Hey everyone! If you're following the auto sector or Tata Motors specifically, the charts are currently painting a very compelling picture. Our in-depth technical analysis of both the weekly and daily charts suggests that Tata Motors (NSE: TATAMOTORS) is gearing up for a significant upward move. Based on the current structure and indicator alignment, we are projecting a medium-term target of ₹800 . Let's break down the evidence from the charts, piece by piece. The Big Picture: Weekly Chart Setup The weekly chart is where the most powerful signals are generated, and for Tata Motors, the weekly view is decidedly bullish. Trend Structure: The stock has successfully broken out of a consolidation phase and is trading firmly above key resistance levels. Price Action: After finding a solid base, the stock has embarked on a clear uptrend, with higher highs and higher lows. The Detailed View: Dail...

🏢 Top 5 Upcoming IPOs in India for October 2025: A Comprehensive Guide October 2025 is shaping up to be a landmark month for India's capital markets, with several high-profile Initial Public Offerings (IPOs) set to open. These offerings span diverse sectors, including technology, finance, and infrastructure, presenting investors with a range of opportunities. Here's a detailed look at the top 5 upcoming IPOs to watch this month: 1. LG Electronics India Ltd. IPO Subscription Dates: October 7–9, 2025 Price Band: ₹1,080 – ₹1,140 per share Issue Size: ₹11,607.01 crore Listing Exchanges: BSE and NSE Lead Manager: Morgan Stanley LG Electronics India is set to debut on the Indian stock exchanges with a substantial IPO aimed at raising over ₹11,600 crore. The company plans to utilize the funds for expansion and debt reduction. With a strong brand presence and a diverse product portfolio, LG aims to leverage its market position to attract investors. 2. Tata Capital ...

  1. Introduction In 2025, Fabtech Technologies IPO is emerging as one of the most talked-about engineering sector IPOs in India. In this blog, we cover every key detail — from the IPO date , price band , and lot size , to GMP (grey market premium) , listing gain potential , and expert investor insight . If you’re planning to apply, this guide will help you make an informed decision. 2. What is Fabtech Technologies? Fabtech Technologies operates in turnkey engineering solutions for pharmaceutical , biotech , and healthcare industries. It handles end-to-end lifecycle: design, engineering, procurement, installation, validation, etc. As of March 2025, it has a robust order book and presence in multiple countries. Understanding the business model is crucial to assessing the IPO’s potential. 3. IPO Key Details Parameter Detail IPO Open Date September 29, 2025 IPO Close Date October 1, 2025 Price Band ₹181 to ₹191 per equity share Lot Size 75 shares...

  RBI Policy Update — Oct 1, 2025: Repo Rate Held at 5.50% The Reserve Bank of India (RBI) left the policy repo rate unchanged at 5.50% in the Monetary Policy Committee (MPC) decision announced on October 1, 2025 . The committee maintained a neutral stance , signaling that it will wait to assess the impact of earlier measures before moving again. What the MPC decided (Quick Summary) Repo rate: 5.50% — unchanged. Policy stance: Neutral — RBI will “wait and watch.” Governor: Sanjay Malhotra chaired the policy announcement. Macroeconomic update: GDP outlook revised to ~6.8%; inflation forecast lowered. Why the Hold Matters for You — Households, Borrowers & Investors Borrowers: With repo held at 5.50%, lending rates and EMIs won’t change immediately. Floating-rate borrowers should not see big shifts in the short term. Savers: Deposit rates may remain stable. Explore short-duration debt funds or high-yield savings options. Investors & Markets: Equity mark...

  Introduction: Tata Motors’ Historic Demerger on October 1, 2025 Tata Motors — India’s leading automobile manufacturer — is undergoing one of its biggest transformations. On October 1, 2025 , the company will officially demerge into two separate entities to unlock value and sharpen focus. For shareholders, this means big changes in how your investment is structured. In this blog, you’ll find everything you need to know about the Tata Motors demerger 2025 — from the 1:1 share entitlement ratio to the record date , new leadership, and how it can impact your portfolio. 1. What is the Tata Motors Demerger? Tata Motors will split its operations into two independent companies: TML Commercial Vehicles Limited (TMLCV) – for trucks, buses, and commercial vehicles. Tata Motors Passenger Vehicles Limited – for passenger cars, electric vehicles (EVs), and Jaguar Land Rover (JLR). This restructuring allows each entity to operate with sharper strategic focus and independent man...

  Introduction In the NDTV Profit “Ask Profit” segment (Sep 29, 2025), analysts answered investor queries on major Indian stocks — Suzlon Energy, Infosys, Tata Motors, Vedanta, Varun Beverages , and others. Their consensus ratings, price zones, and caveats offer actionable insights for traders and long-term investors alike. Below is a deep dive, structured for clarity and with strategic takeaways. Analyst Ratings & Key Takeaways Here’s a summary of the Buy / Sell / Hold calls given by Saurabh Jain (SMC Global), Gaurav Bissa (Incred Equities), and Ajit Mishra (Religare Broking): Stock Current Price (as per article) Rating Analyst’s Rationale / Notes Vedanta ₹452.25 Hold Bissa suggests to hold with a stop loss at ₹448, noting the stock is range-bound and better alternatives exist. Tata Motors ₹672.50 Buy (post demerger) Jain expects the Indian business to perform better after the demerger; festive season momentum also helps. Varun Beverages ₹451.70 ...

  Introduction In its latest research report (dated September 29, 2025), Motilal Oswal has reiterated a “Buy” rating on Bharat Electronics (BHEL / BHE) , raising the target price to ₹490 . This recommendation stems from a surge in defence sector orders, solid earnings projections, and new opportunities in missile systems and electronics warfare. In this post, we analyze why analysts are bullish , the key risks, and whether this stock deserves your attention as a long-term or medium-term bet. Key Highlights from the Motilal Oswal Report Major QRSAM Tender The Indian Army has placed a tender for the QRSAM / “Anant Shastra” surface-to-air missile system, to be integrated by Bharat Electronics. This deal is estimated at around INR 300 billion and will add 5–6 regiments to the order book. Order Book Strength & Big Ticket Contracts With this order, BHE’s order book is estimated to cross ₹1 trillion . Further potential growth from: Electronics warfare contracts ...

  Introduction Tata Capital’s IPO is among the most anticipated listings in 2025. As an “upper-layer NBFC”, it is mandated by the RBI to list within a period, adding urgency and intrigue. In this post, we deep-dive into the price band , GMP (Grey Market Premium) , key dates , issue structure , and listing outlook for Tata Capital IPO. What Is Tata Capital & Why IPO? Tata Capital Ltd. is a diversified financial services company under the Tata Group, offering consumer loans, commercial finance, wealth management and more. Because Tata Capital is classified as an “upper-layer NBFC,” RBI norms require it to get listed within a stipulated timeframe. Thus, the IPO not only raises capital but also helps comply with regulatory requirements. Tata Capital IPO — Key Details & Structure Parameter Details IPO Open Date 6 October 2025 IPO Close Date 8 October 2025 Basis of Allotment 9 October 2025 (tentative) Refund / Share Credit 10 October 2025 (refunds p...

1. Introduction / Hook The Tata Group’s Titan Company has just drawn the spotlight from global brokerage Nomura , which has initiated coverage with a ‘Buy’ rating and pegged a target price of ₹4,275 , implying over 25% upside from current levels. In this post, we deep dive into why Nomura is bullish, Titan’s financials, key risks, and whether this is a good buy in 2025. 2. What Did Nomura Say? Nomura’s first coverage on Titan comes with a Buy rating and a target of ₹4,275 — ~27% above current market levels. They highlight Titan’s strong presence in the discretionary consumption space, and believe the firm is well positioned to benefit from robust demand across jewellery and lifestyle verticals. According to Nomura, margin pressures are largely behind Titan, and concerns over profitability are overdone. 3. Titan’s Recent Performance & Highlights Titan’s market capitalization is ~₹3,01,030 crores. Over the last year, the stock has underperformed — delivering a ~−9.7% ...

  Introduction In volatile markets, identifying stocks with strong fundamentals and long runway for growth is key. Recently, analysts have flagged seven names — five largecap and two midcap — as compelling picks for long-term portfolios. Among them are popular names like Vedant Fashions and JSW Infrastructure, which stand out for their sectoral advantages and demonstrable growth potential.  In this blog, we’ll dig into why these stocks have captured analyst attention, what makes them promising, and how to evaluate them for your own portfolio. --- Why Analysts Are Eyeing These 7 Stocks Before we jump into the names, here are a few common themes motivating the recommendations: Strong business models & scalability: Many companies operate in growth sectors (infrastructure, apparel, steel) or have diversified operations. Favorable macro tailwinds: Infrastructure spending, rising consumption, domestic demand, policy support, etc. Valuation + upside: Analysts believe current valu...

  Introduction : Motilal Oswal, one of India’s leading brokerage houses, recently released a set of high-potential buy recommendations that have grabbed investors’ attention. With an impressive upside potential of up to 28%, these stocks could offer significant returns in the medium term. In this post, we break down each recommendation, the rationale behind them, and the market dynamics that make them compelling. --- 1. Hindustan Aeronautics Limited (HAL) Target Price: ₹5,800 (+21%) Why Buy: HAL has recently secured a massive defense order worth ₹62,400 crore, strengthening its long-term revenue stream. With strong government backing and consistent execution, HAL is well-positioned for sustainable growth. Key Insights: Robust order book in aerospace and defense. Expansion in fighter aircraft and helicopter segments. Strong financial health with stable margins. --- 2. Grasim Industries Target Price: ₹3,550 (+28%) Why Buy: Grasim is expanding aggressively in the paints and B2B e-comm...

  Published: 27 September 2025 (Data and market moves cited to major outlets — closing numbers and market drivers are from 26–27 Sep 2025 market coverage.) Indian benchmark indices fell sharply on Friday as selling in pharma and IT stocks, renewed U.S. trade & visa measures, foreign fund outflows and a weaker rupee pushed the market to a three-week low. The BSE Sensex slid roughly 733 points to ~80,426 while the NSE Nifty 50 dropped to about 24,655 , marking an over-three-week low for both indices. ( mint ) Trend breakdown — Sensex / Nifty / stock market: Why the market is down today — 10 point explainer Immediate trigger — U.S. tariffs on branded pharmaceuticals. President Trump’s announcement of steep tariffs (including a 100% levy on certain branded/patented drugs) rattled global pharma flows and triggered a sharp sell-off in India’s pharma pack. Indian pharma stocks led losses on the day. ( Reuters ) H-1B fee/executive action hit IT sentiment. A new six-figure...

In a surprise move on Sept. 25, 2025, U.S. President Donald Trump announced a 100% tariff on imports of branded or patented pharmaceutical products effective October 1, 2025 — unless the manufacturer has already started building a U.S. manufacturing plant. The announcement sent global markets reeling and hit Indian pharma counters hard, with major names like Sun Pharma , Cipla , and Dr Reddy’s seeing immediate share pressure. ( Reuters ) What Trump announced (quick facts) The tariff: 100% on imports of branded/patented pharmaceuticals starting Oct 1, 2025 . ( Reuters ) Carve-out: companies that have begun construction of U.S. manufacturing sites (defined as “breaking ground” or “under construction”) are reportedly exempt. ( Reuters ) Immediate market reaction Markets reacted quickly. The Nifty Pharma index and individual pharma stocks fell after the announcement — Reuters reports the Indian pharma index and stocks like Sun Pharma were down significantly, with Sun P...